In this study, we found that with integration of the HER2 status, a clinical prediction model and an effective nomogram could predict EGC lymph node metastasis with better accuracy and clinical performance. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.